HER2 testing: The evolving role of immunohistochemistry – best practices and interpretation of results in lung and ovarian cancer

  • calender Tuesday, 11th March, 2025
  • clock 17:30h - 19:00h (UTC)

A virtual Experts Knowledge Share on the topic of ‘HER2 testing: The evolving role of immunohistochemistry – best practices and interpretation of results in lung and ovarian cancer’, chaired by Prof. Fernando López-Ríos (Spain) and co-chaired by Prof. Charlie Gourley (UK) and Prof. Christian Rolfo (US).  

Topics of conversation include: 

  1. An overview of challenges related to HER2 immunohistochemistry, practical guidance and interpretation of the results
  2. Targeting HER2 in lung cancer: where does IHC testing fit in?
  3. Ovarian cancer: Challenges and considerations for HER2 IHC testing
  4. A panel discussion amongst speakers and participants engaging in a Q&A to address pressing issues

This event is in collaboration with PRECISION ONCOLOGY CONNECT, a group of international experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers. 

Don’t miss the opportunity to contribute to the discussion on this important topic. This meeting is intended for HCPs only.

Please complete the Pre-meeting survey (link can be found at the bottom of this page), to ensure we optimise your valuable time during the meeting.

Submit your patient case study/questions for the faculty to selina.gill@cor2ed.com by 28th February 2025.

endorsement

PRECISION ONCOLOGY CONNECT is an initiative of COR2ED. This programme is supported by an Independent Medical Education Grant from AstraZeneca.